BearingPoint launches new services to help organizations gain full software transparency and meet EU Cyber Resilience Act requirements ahead of the 2027 deadline
24.2.2026 09:00:00 CET | Business Wire | Press Release
BearingPoint announces the launch of two new service offerings designed to address the growing complexity of software supply chains and the upcoming regulatory requirements under the EU Cyber Resilience Act (CRA): SBOM Management Services and CRA Compliance Services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224192962/en/
BearingPoint announces the launch of two new service offerings designed to address the growing complexity of software supply chains and the upcoming regulatory requirements under the EU Cyber Resilience Act (CRA): SBOM Management Services and CRA Compliance Services.
Modern software products often contain thousands of components, many of which are open source or sourced from third-party suppliers. As supply chain attacks become more frequent and regulations tighten, organizations need complete visibility into their software composition to manage risk effectively and meet compliance obligations. The EU Cyber Resilience Act, which comes into full effect in December 2027, mandates that manufacturers demonstrate exactly what is inside their products and how vulnerabilities are managed throughout the product lifecycle.
An integrated approach to software transparency and compliance
BearingPoint's SBOM Management Services deliver the foundational visibility that organizations require. The service covers the entire Software Bill of Materials (SBOM) lifecycle: strategy and readiness assessment, generation and integration into development workflows, quality assurance against industry standards such as CycloneDX and SPDX, vulnerability and license risk analytics, governance and policy implementation, supplier management, and audit-ready reporting.
Building on this foundation, BearingPoint's CRA Compliance Services ensure that software transparency translates into regulatory conformity. The service includes comprehensive OSS inventory and risk assessment, vulnerability management processes aligned with CRA reporting obligations, cybersecurity policy development, compliance documentation, and targeted training for engineering and compliance teams.
While the two services address distinct challenges, they are closely connected. SBOM management provides the structured, automated visibility that CRA compliance requires. Together, they enable organizations to understand their software composition, manage risks proactively, and demonstrate conformity to regulators and customers alike.
What sets BearingPoint apart
BearingPoint brings a distinctive combination of capabilities to these services. The firm offers an operational, end-to-end model that covers SBOM generation, quality assurance, policy enforcement, mitigation workflows, and audit support. The approach is vendor-agnostic and tool-neutral, adapting to each client's existing infrastructure rather than requiring specific technology choices.
With deep experience in open source license governance and compliance, BearingPoint is uniquely positioned to unify license, security, and compliance risk into a single SBOM-driven model. Both services are aligned with current and emerging regulations, including the CRA, NIS2, and U.S. Executive Order 14028.
Organizations can engage flexibly: starting with a pilot program, scaling to a full operating model, or fully outsourcing ongoing SBOM management to BearingPoint.
Industry perspectives
“The world around us is becoming increasingly digital, and every device we use today is built on software. Open source is everywhere and a key driver of innovation. At the same time, the risk of cyberattacks and incompliance is growing, and the need for real cyber resilience is becoming critical. With regulations such as the EU Cyber Resilience Act, this responsibility will soon be mandatory rather than optional. This is exactly where our new outcome‑based service comes in: we combine best‑of‑breed software with deep expert capabilities and take end‑to‑end responsibility for ensuring software compliance and security for our clients. Not as a one‑off effort, but as a measurable, sustainable outcome,” says Frank Duscheck, Partner at BearingPoint.
“Once SBOMs become fully enforceable by the CRA, SBOM management is no longer a ‘nice to have’. In the light of the CRA’s lifecycle security and accountability requirements, SBOM management becomes the foundation for security by design, not just a compliance checkbox. Companies that invest early turn regulatory pressure into a competitive advantage. Our new CRA Compliance and SBOM Management services are a powerful instrument for companies of any size to make their CRA compliance journey smooth, efficient, and sustainable,” adds Claus-Peter Wiedemann, Director Software Services, at BearingPoint.
BearingPoint's SBOM Management Services and CRA Compliance Services are available now. To learn more or schedule a consultation, visit:
SBOM Management Services: https://bearingpoint.services/foss/en/our-services/sbom-management-services/
CRA Compliance Services : https://bearingpoint.services/foss/en/our-services/cyber-resilience-act-cra-compliance-services/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. We help businesses transform by combining deep industry expertise with strong capabilities in strategy, operations, and technology. Dedicated SAP and Microsoft transformation units, a strong focus on AI, and outcome-based products enable us to provide tailored, innovative solutions that create measurable and sustainable value.
In addition to our core consulting operations, we run two joint ventures. Arcwide, our joint venture with IFS, specializes in business transformation enabled by IFS technology. BearingPoint North America, our joint venture with ABeam Consulting, focuses on consulting excellence and business transformation built on SAP.
BearingPoint works with many of the world’s leading companies and public-sector organizations. Together with its strategic alliance partner ABeam Consulting, the firm brings together more than 15,000 professionals and serves clients in over 70 countries, delivering seamless business transformation, strengthening performance, and driving sustainable impact.
BearingPoint is recognized among TIME World’s Best Companies and Forbes World’s Best Employers. The firm is also a certified B Corporation, committed to responsible business and creating long-term value for organizations, people, and society.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
View source version on businesswire.com: https://www.businesswire.com/news/home/20260224192962/en/
Contacts
Press contact
Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
Email: alexander.bock@bearingpoint.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom